Clinical Trial Results TV
SPIRIT III: Trial designed to compare Abbott’s XIENCE V Everolimus Eluting Coronary Stent System with Boston Scientifi
SPIRIT III: Trial designed to compare Abbott’s XIENCE V Everolimus Eluting Coronary
Stent System with Boston Scientific's TAXUS Paclitaxel-Eluting Coronary Stent System Gregg
W. Stone, MD

Sponsorship for the booth and interviews at ACC 2007 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from the Medicines Company,
Merck, Schering-Plough and Scios.

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
11-24-2024 EST at 1 am.

Additional Files
Filename File Description Action
278.ppt SPIRIT Slides Download

Comments [ login to comment ]
No comments have been submitted